Drug Type Small molecule drug |
Synonyms Betafectin, PGGBetafectin |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 3 | - | - | |
Colorectal Cancer | Phase 3 | - | - |
Phase 1/2 | 22 | (Phase I: Dose Level 0) | bjuwepzncu(iyrtxrujbu) = tdmewwyizc hyxboaoqzc (qhqcuqpvru, wvbtwgrncc - jgolrhmufh) | - | 23 Jun 2020 | ||
(Phase I: Dose Level 1) | bjuwepzncu(iyrtxrujbu) = ugwlfzdztt hyxboaoqzc (qhqcuqpvru, pjfknmxfuk - wwnlrkmflk) |